Crumlin, UK, 9 September 2010 -- In a point-of-care setting, tests are often carried out by nurses at, or near the patient’s bedside. It is therefore extremely important for control material to be convenient, quick and easy to use. The Randox range of liquid ready to use controls offer a range of benefits making them user friendly and suitable for use by non laboratory personnel. Very little training is necessary as controls are liquid stable and ready to use. By eliminating the need for dilution or reconstitution the risk of human error is minimised. Liquid stable controls also eliminate the need to thaw controls before use; freeing up precious staff time while colour coded caps allow different levels to be identified quickly and easily; reducing the risk of costly errors.
Control products include:
• Blood Gas – Multi-analyte control with assayed values provided for 10 analytes, method specific target values and ranges are also quoted for the most common instruments.
• Liquid Cardiac – Assayed values are provided for 10 analytes including Troponin I + T, D-dimer and NT-proBNP. An open vial stability of up to 30 days at 2-8oC minimises waste.
• Drugs of Abuse – Assayed values are provided for 13 different drugs of abuse. An open vial stability of 30 days at 2-8oC minimises waste.
• Urinalysis – Multi-analyte control containing assayed values for 13 analytes. Designed for use with a wide range of test strip manufacturers with an open vial stability of 30 days at 2-8oC.
Until recently, quality control was thought to be unnecessary in the point-of-care field. However due to the large increase in the number of point-of-care tests available quality control has become crucial not only in preventing misdiagnosis but in reducing turnaround time and saving money.
There is now an international standard specifically for point-of-care testing; ISO 22870. This standard is intended to be used in conjunction with the standard for medical laboratories, ISO 15189. This means that aspects such as training, competence and documentation should be carefully planned, implemented and governed by a quality management system and there is a requirement for IQC and EQA to be performed, where available.
About Randox
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.
For more information contact us at marketing@randox.com
